Hogy Medical Co.,Ltd.
3593.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.72 | -0.92 | 1.09 | -3.15 |
| FCF Yield | 6.08% | 4.77% | 10.11% | 5.73% |
| EV / EBITDA | 11.32 | 7.17 | 6.82 | 8.60 |
| Quality | ||||
| ROIC | 2.00% | 3.04% | 4.87% | 4.60% |
| Gross Margin | 32.25% | 31.95% | 40.38% | 41.92% |
| Cash Conversion Ratio | 7.74 | 2.54 | 1.48 | 1.35 |
| Growth | ||||
| Revenue 3-Year CAGR | 0.13% | 2.06% | 2.21% | -0.41% |
| Free Cash Flow Growth | 51.27% | -44.55% | 46.87% | 872.59% |
| Safety | ||||
| Net Debt / EBITDA | -0.95 | -1.27 | -1.01 | -0.43 |
| Interest Coverage | 49.43 | 181.26 | 228.76 | 1,022.50 |
| Efficiency | ||||
| Inventory Turnover | 2.67 | 2.81 | 2.62 | 2.42 |
| Cash Conversion Cycle | 178.02 | 182.55 | 175.67 | 188.99 |